Skip to main content
Premium Trial:

Request an Annual Quote

Children's National Licenses Pediatric Genetic Disease Screening Tech to MGeneRx

NEW YORK — Children's National Hospital said on Wednesday that it has exclusively licensed a patented technology for early, noninvasive screening of dysmorphic genetic diseases in pediatric patients to startup MGeneRx.

Financial and other terms of the deal were not disclosed.

The technology uses artificial intelligence to analyze a patient's face and identify facial markers that are indicative of 128 different genetic disorders — including DiGeorge, Down, Williams, and Noonan syndromes — with about 90 percent accuracy. It runs on a smartphone application that uses a phone's camera and provides results immediately, according to Morrisville, North Carolina-based MGeneRx, which was spun off of BreakThrough BioAssets earlier this year.

Washington, D.C.-based Children's National said that MGeneRx aims to raise funding to commercialize the technology, with a focus on markets in developing nations with limited access to genetic testing, and to expand its application to additional disorders.

FDNA is developing a similar technology, called Face2Gene, that uses facial anomalies, phenotypic traits, and variant information to diagnose genetic disorders.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.